Korsana Biosciences annual free cash flow
2018
2019
2020
2021
2022
Korsana Biosciences Free Cash Flow (FCF) History (KRSA)
Korsana Biosciences reported −$40.6M in free cash flow for fiscal 2022, a decrease of $4.1M from the previous fiscal year, with a free cash flow margin of −13673.74%.
View full Korsana Biosciences company overviewKorsana Biosciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$40.6M | −$4.1M | — | −13673.74% |
| 2021 | 2021-12-31 | −$36.5M | $37.5M | — | −926.53% |
| 2020 | 2020-12-31 | −$74.0M | $35.1M | — | −3223.61% |
| 2019 | 2019-12-31 | −$109.1M | −$8.2M | — | −2420.75% |
| 2018 | 2018-12-31 | −$100.9M | — | — | — |
Korsana Biosciences quarterly free cash flow
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$1.4M | −$929,000 | — | — |
| Q1 2026 | 2026-03-31 | −$1.2M | −$274,000 | — | — |
| Q2 2025 | 2025-06-30 | −$503,000 | — | — | −540.86% |
| Q1 2025 | 2025-03-31 | −$968,000 | — | — | −1195.06% |
| Q4 2020 | 2020-12-31 | −$14.1M | $8.3M | — | −10583.46% |
| Q3 2020 | 2020-09-30 | −$15.1M | $9.4M | — | −3764.25% |
| Q2 2020 | 2020-06-30 | −$14.3M | $11.9M | — | −1908.68% |
| Q1 2020 | 2020-03-31 | −$30.6M | $5.5M | — | −3016.27% |
| Q4 2019 | 2019-12-31 | −$22.3M | $2.6M | — | — |
| Q3 2019 | 2019-09-30 | −$24.5M | $2.0M | — | −1750.00% |
| Q2 2019 | 2019-06-30 | −$26.2M | −$3.3M | — | −1610.32% |
| Q1 2019 | 2019-03-31 | −$36.1M | −$9.5M | — | — |
| Q4 2018 | 2018-12-31 | −$25.0M | — | — | — |
| Q3 2018 | 2018-09-30 | −$26.5M | — | — | — |
| Q2 2018 | 2018-06-30 | −$22.9M | — | — | — |
| Q1 2018 | 2018-03-31 | −$26.6M | — | — | — |
Korsana Biosciences free cash flow growth trends
Korsana Biosciences's latest reported quarter, Q2 2026, generated −$1.4M in free cash flow, a decrease of $929,000 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Korsana Biosciences source filings ↗